Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant in Adults With Prader-Willi Syndrome
NCT00603109Phase 3Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Aug 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Prader-Willi syndrome (PWS) comparing Rimonabant with Placebo (2 arms). Primary endpoints: Body Weight at 6 months and Body Fat Mass at 6 months. Started Aug 2007; status: terminated.
02
Drugs
rimonabant
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT00603109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00603109.